Memory B cells activate brain-homing, autoreactive CD4 + T cells in multiple sclerosis
The STEP trial program examining higher-dose semaglutide (2.4 mg weekly) for weight management demonstrated mean weight loss of 12% to 15% over 68 weeks in adults with obesity, significantly exceeding placebo
Side Effects and Tolerability Considerations Both medications share gastrointestinal side effects: nausea, vomiting, diarrhea, and constipation
Whats New in Primary Care: Spring 25 Hello everyone
The shortage list removal The FDA officially removed tirzepatide from its drug shortage list in late fall of the previous year
Research and development expenses, along with regulatory compliance expenditures, play a crucial role in determining the overall retatrutide cost of the treatment